News | April 25, 2023
Xyall and Indica Labs forge collaboration to transform precision oncology workflows
Bridging the gap between histopathology and molecular pathology
Bridging the gap between histopathology and molecular pathology
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022
Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
Subscribe To Our Newsletter & Stay Updated
